Alexandra Maclean serves as Executive at AVENUE THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Alexandra Maclean has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 23, 2024 involved receiving (via award) 170,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 23, 2024 | ATXI | $0 | Award | 170,000 | $N/A | Discretionary |
Alexandra Maclean currently holds 170,000 shares of AVENUE THERAPEUTICS, INC. (ATXI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alexandra Maclean has been a net neutral trader of ATXI stock. They have purchased $0 and sold $0 worth of shares.
Alexandra Maclean's most recent insider trade was on Sep 23, 2024, when they sold 170,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted